FDA Approved: PEMAZYRE — Original Application (Incyte Corporation)

View source ↗

Summary

FDA approval of Pemazyre (pemigatinib) from Incyte as an original application for the treatment of cholangiocarcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholangiocarcinoma

Drugs mentioned

• Pemazyre (pemigatinib)

Snippet

ORIG AP for PEMAZYRE (PEMIGATINIB)